Prosecution Insights
Prosecution Insights
9 pending office actions • 7 art units • 8 examiners • 0 of 9 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (44%) |
| §102 only | 2 (22%) |
| §112 only | 1 (11%) |
| No statute on record | 2 (22%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REGA, KYLE THOMAS | 2 | 62.4% | +43.9% |
| BREEN, KIMBERLY CATHERINE | 1 | 26.0% | +58.6% |
| NOAKES, SUZANNE MARIE | 1 | 73.1% | +18.3% |
| SHTERENGARTS, SAMANTHA L | 1 | 79.4% | +7.9% |
| MOORE, SUSANNA | 1 | 68.1% | +31.8% |
| PATEL, SAGAR S | 1 | 76.1% | +33.8% |
| YU, DAVID TUYANG | 1 | — | — |
| DACE DENITO, ALEXANDRA GERALDINE | 1 | 56.5% | +36.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18486913 | ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE | BREEN, KIMBERLY CATHERINE | 70d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17430289 | SPLICE ACCEPTOR SITE DISRUPTION OF A DISEASE-ASSOCIATED GENE USING ADENOSINE DEAMINASE BASE EDITORS, INCLUDING FOR THE TREATMENT OF GENETIC DISEASE | REGA, KYLE THOMAS | 91d overdue |
| 18486913 | ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE | BREEN, KIMBERLY CATHERINE | 70d overdue |
| 18460178 | USES OF ADENOSINE BASE EDITORS | NOAKES, SUZANNE MARIE | 42d overdue |
| 17430669 | ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE | REGA, KYLE THOMAS | 24d overdue |
| 18211840 | NANOMATERIALS COMPRISING CARBONATES | PATEL, SAGAR S | 17d overdue |
| 18220874 | IONIZABLE LIPIDS FOR NANOMATERIALS | MOORE, SUSANNA | 27d |
| 17430274 | COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A | DACE DENITO, ALEXANDRA GERALDINE | 70d |
| Art Unit | Apps |
|---|---|
| 1636 | 3 |
| 1657 | 1 |
| 1656 | 1 |
| 1623 | 1 |
| 1624 | 1 |
| 1626 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18486913 | ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE | BREEN, KIMBERLY CATHERINE | 1657 | §103 | Non-Final OA | 70d overdue | Pending | Oct 13, 2023 |
| 18460178 | USES OF ADENOSINE BASE EDITORS | NOAKES, SUZANNE MARIE | 1656 | Other | Final Rejection | 42d overdue | Pending | Sep 01, 2023 |
| 18220867 | NANOMATERIALS COMPRISING AN IONIZABLE LIPID | SHTERENGARTS, SAMANTHA L | 1623 | §102 | Non-Final OA | 14d | Pending | Jul 12, 2023 |
| 18220874 | IONIZABLE LIPIDS FOR NANOMATERIALS | MOORE, SUSANNA | 1624 | §103 | Non-Final OA | 27d | Pending | Jul 12, 2023 |
| 18211840 | NANOMATERIALS COMPRISING CARBONATES | PATEL, SAGAR S | 1626 | §102 | Non-Final OA | 17d overdue | Pending | Jun 20, 2023 |
| 18031547 | COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A | YU, DAVID TUYANG | 1635 | Other | Non-Final OA | 23d overdue | Pending | Apr 12, 2023 |
| 17430669 | ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE | REGA, KYLE THOMAS | 1636 | §103 | Non-Final OA | 24d overdue | Pending | Aug 12, 2021 |
| 17430289 | SPLICE ACCEPTOR SITE DISRUPTION OF A DISEASE-ASSOCIATED GENE USING ADENOSINE DEAMINASE BASE EDITORS, INCLUDING FOR THE TREATMENT OF GENETIC DISEASE | REGA, KYLE THOMAS | 1636 | §112 | Final Rejection | 91d overdue | Pending | Aug 11, 2021 |
| 17430274 | COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §103 | Non-Final OA | 70d | Pending | Aug 11, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial